We are live on ! Find out more
MA

Montag & Associates Portfolio holdings

AUM $2.15B
1-Year Est. Return 20.86%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+20.86%
3 Year Est. Return
+68%
5 Year Est. Return
+82.09%
10 Year Est. Return
+321.81%
AUM
$613M
AUM Growth
+$21.7M
Cap. Flow
-$3.21M
Cap. Flow %
-0.52%
Top 10 Hldgs %
22.48%
Holding
251
New
18
Increased
52
Reduced
87
Closed
9

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$4.1M
2
LLY icon
Eli Lilly
LLY
+$3.04M
3
INGR icon
Ingredion
INGR
+$2.73M
4
CSCO icon
Cisco
CSCO
+$2.62M
5
TDW icon
Tidewater
TDW
+$2.35M

Top Sells

Rank Stock Value
1
CF icon
CF Industries
CF
+$4.8M
2
HII icon
Huntington Ingalls Industries
HII
+$3.97M
3
WY icon
Weyerhaeuser
WY
+$3.94M
4
OMC icon
Omnicom Group
OMC
+$3.72M
5
CTRA
Coterra Energy
CTRA
+$2.64M

Sector Composition

Rank Sector Weight
1 Healthcare 12.05%
2 Financials 10.79%
3 Industrials 9.01%
4 Consumer Staples 8.86%
5 Technology 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
51
AbbVie
ABBV
$469B
$3.74M 0.61%
66,245
+2
+0% +$105
HII icon
52
Huntington Ingalls Industries
HII
$11.4B
$3.69M 0.6%
39,061
-39,705
-50% -$3.97M
ALSN icon
53
Allison Transmission
ALSN
$10.1B
$3.58M 0.58%
115,190
+7,880
+7% +$238K
PG icon
54
Procter & Gamble
PG
$352B
$3.51M 0.57%
44,690
-121
-0.3% -$9.76K
JPM icon
55
JPMorgan Chase
JPM
$947B
$3.5M 0.57%
60,820
+502
+0.8% +$28.2K
LLY icon
56
Eli Lilly
LLY
$1.09T
$3.47M 0.57%
55,870
+50,940
+1,033% +$3.04M
CBRE icon
57
CBRE Group
CBRE
$43.4B
$3.13M 0.51%
97,825
-15,405
-14% -$445K
GPC icon
58
Genuine Parts
GPC
$17.9B
$3.13M 0.51%
35,603
– –
RDS.A
59
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$3.11M 0.51%
37,792
+6
+0% +$469
GLW icon
60
Corning
GLW
$104B
$3.08M 0.5%
140,365
-1,422
-1% -$30.2K
GLD icon
61
SPDR Gold Trust
GLD
$131B
$3.07M 0.5%
23,945
-375
-2% -$46.6K
IJH icon
62
iShares Core S&P Mid-Cap ETF
IJH
$123B
$2.99M 0.49%
104,550
-1,750
-2% -$48.1K
KRE icon
63
State Street SPDR S&P Regional Banking ETF
KRE
$4.53B
$2.98M 0.49%
74,000
– –
CSCO icon
64
Cisco
CSCO
$458B
$2.98M 0.49%
119,830
+109,772
+1,091% +$2.62M
WRB icon
65
W.R. Berkley
WRB
$28.4B
$2.86M 0.47%
208,373
– –
INGR icon
66
Ingredion
INGR
$6.45B
$2.82M 0.46%
+37,600
New +$2.73M
WKC icon
67
World Kinect Corp
WKC
$2.05B
$2.82M 0.46%
57,210
+32,098
+128% +$1.47M
BRK.B icon
68
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.76M 0.45%
21,794
-280
-1% -$35.4K
TWX
69
DELISTED
Time Warner Inc
TWX
$2.75M 0.45%
39,216
+34,871
+803% +$2.29M
CTRA
70
DELISTED
Coterra Energy
CTRA
$2.72M 0.44%
79,650
-73,630
-48% -$2.64M
EOG icon
71
EOG Resources
EOG
$74.4B
$2.69M 0.44%
23,025
-8,465
-27% -$890K
COF icon
72
Capital One
COF
$129B
$2.66M 0.43%
32,203
– –
BAC icon
73
Bank of America
BAC
$439B
$2.65M 0.43%
172,635
-27,290
-14% -$424K
MSFT icon
74
Microsoft
MSFT
$2.96T
$2.61M 0.43%
62,570
+56,482
+928% +$2.29M
TDW icon
75
Tidewater
TDW
$3.74B
$2.57M 0.42%
+1,418
New +$2.35M
1 2
3
4 5

Similar funds

IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.16B AUM 18.08% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return

Montag & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Montag & Associates held 251 positions worth $613M, up 3.7% from $592M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Montag & Associates's Q2 2014 filing shows 18 new, 52 increased, 87 reduced and 9 closed positions. Its largest new stake was Gilead Sciences: 52,627 shares worth $4.36M. The largest sale was CF Industries, an estimated $4.8M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Montag & Associates's largest Q2 2014 buy was Gilead Sciences: 52,627 shares worth $4.36M.
  • Montag & Associates added most to Eli Lilly in Q2 2014, an estimated $3.04M increase.
  • Montag & Associates's biggest Q2 2014 reduction was Huntington Ingalls Industries, cutting an estimated $3.97M.
  • Montag & Associates fully exited CF Industries in Q2 2014, selling an estimated $4.8M.
  • Montag & Associates's ten largest holdings make up 22% of its $613M portfolio in Q2 2014.
  • Montag & Associates opened 18 new positions and closed 9 in Q2 2014.
  • Montag & Associates's portfolio value rose 3.7% quarter-over-quarter to $613M.

Based on Montag & Associates's 13F filing for Q2 2014, filed 6 Aug 2014.